
    
      Choroidal neovascularization is a hallmark of angioid streaks, and presumably VEGF-driven.
      Ranibizumab has been shown to be effective in CNV secondary to age-related macular
      degeneration. Therefore, we hypothesize that ranibizumab may be efficacious in the treatment
      of CNV secondary to angioid streaks
    
  